Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.38+0.59 (+12.32%)
At close: 04:00PM EDT
5.36 -0.02 (-0.37%)
After hours: 07:52PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
3/31/2022
3/31/2021
3/31/2020
Total Revenue
0
0
0
0
Operating Expense
166,522
156,033
108,117
66,078
Operating Income
-166,522
-156,033
-108,117
-66,078
Net Non Operating Interest Income Expense
-
-
0
-625
Other Income Expense
199
-781
328
412
Pretax Income
-166,323
-156,814
-107,789
-66,291
Tax Provision
309
-84
-358
97
Net Income Common Stockholders
-166,632
-156,730
-107,431
-66,388
Diluted NI Available to Com Stockholders
-166,632
-156,730
-107,431
-66,388
Basic EPS
-
-1.43
-1.22
-1.54
Diluted EPS
-
-1.43
-1.22
-1.54
Basic Average Shares
-
109,679
87,757
43,199
Diluted Average Shares
-
109,679
87,757
43,199
Total Expenses
166,522
156,033
108,117
66,078
Net Income from Continuing & Discontinued Operation
-166,632
-156,730
-107,431
-66,388
Normalized Income
-166,632
-156,730
-107,431
-66,388
Interest Expense
-
-
0
625
Net Interest Income
-
-
0
-625
EBIT
-166,522
-156,033
-107,789
-65,666
EBITDA
-166,378
-
-
-
Reconciled Depreciation
144
126
65
21
Net Income from Continuing Operation Net Minority Interest
-166,632
-156,730
-107,431
-66,388
Normalized EBITDA
-166,378
-155,907
-107,724
-65,645
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement